Note 11 - Restatement of Previously Issued (Unaudited) Interim Financial Statements - Schedule of Error Corrections (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Deferred offering costs	$ 247,671	$ 638,018	$ 0
General and administrative	2,127,930	1,000,913
Accumulated deficit	(56,955,124)	(52,803,252)	(54,440,789)
Total operating expenses	4,942,188	2,834,187
Total assets	7,997,448	3,943,495	9,972,521
Loss from operations	(2,594,938)	(1,426,319)
Total liabilities, convertible preferred stock and stockholder’s deficit	7,997,448	3,943,495	9,972,521
Net loss	(2,514,335)	(534,336)
Total stockholders’ deficit	$ 5,336,378	$ (33,748,155)	$ 7,376,774
Net loss per share of common stock, basic and diluted (in dollars per share)	$ (0.41)	$ (1.03)
Previously Reported [Member]
Deferred offering costs		$ 0
General and administrative		1,638,931
Accumulated deficit		(53,441,270)
Total operating expenses		3,472,205
Total assets		3,305,477
Loss from operations		(2,064,337)
Total liabilities, convertible preferred stock and stockholder’s deficit		3,305,477
Net loss		(1,172,354)
Total stockholders’ deficit		$ (34,386,173)
Net loss per share of common stock, basic and diluted (in dollars per share)		$ (2.26)
Revision of Prior Period, Error Correction, Adjustment [Member]
Deferred offering costs		$ 638,018
General and administrative		(638,018)
Accumulated deficit		638,018
Total operating expenses		(638,018)
Total assets		638,018
Loss from operations		638,018
Total liabilities, convertible preferred stock and stockholder’s deficit		638,018
Net loss		638,018
Total stockholders’ deficit		$ 638,018
Net loss per share of common stock, basic and diluted (in dollars per share)		$ 1.23